Overall, these results suggest that B3GNT8 is essential for maintaining Paneth cell function and intestinal homeostasis through its glycosylation activities, potentially leading to new therapeutic strategies for IBD. The gene discussed is B3GNT8; the disease is inflammatory bowel disease.